$27.43 +0.85 (%) Quidel Corp - NASDAQ

Dec. 18, 2014 | 11:19 AM

Partner Headlines

  1. Quidel Announces Pricing of $150 Million Convertible Senior Notes Offering

    GuruFocus | Dec. 3, 2014 | 00:01AM EST
  2. Mid-Day Losers From December 2: NTELOS Holdings, Quidel, Mattress Firm, Thor Industries

    Benzinga | Dec. 2, 2014 | 13:50PM EST
  3. Mid-Day Market Update: General Motors November US Auto Sales Surge; Vince Holding Shares Slide

    Benzinga | Dec. 2, 2014 | 13:30PM EST
  4. Mid-Morning Market Update: Markets Open Higher; Cypress To Acquire Spansion In $4 Billion Deal

    Benzinga | Dec. 2, 2014 | 10:26AM EST
  5. Morning Market Losers

    Benzinga | Dec. 2, 2014 | 09:47AM EST
  6. Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human ...

    GuruFocus | Oct. 15, 2014 | 16:04PM EST
  7. Top Insider Buys Highlight: Quidel Corporation

    GuruFocus | Jul. 28, 2014 | 19:10PM EST
  8. Mid-Afternoon Market Update: Apple Hangs onto Gains as Fusion-io Drops on Earnings

    Benzinga | Apr. 24, 2014 | 15:19PM EST
  9. Mid-Day Market Update: US Stocks Turn Higher; Apple Shares Jump On Upbeat Results

    Benzinga | Apr. 24, 2014 | 13:47PM EST
  10. Mid-Morning Market Update: Markets Drop; GM Earnings Beat Estimates

    Benzinga | Apr. 24, 2014 | 10:28AM EST
  11. Morning Market Losers

    Benzinga | Apr. 24, 2014 | 09:55AM EST
  12. Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Herpes Simplex Virus Types 1 and 2

    Benzinga | Mar. 27, 2014 | 16:06PM EST
  13. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Jan. 30, 2014 | 04:47AM EST
  14. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Dec. 18, 2013 | 04:28AM EST
  15. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue Estimates

    Benzinga | Nov. 12, 2013 | 06:28AM EST
  16. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

    Benzinga | Nov. 6, 2013 | 05:20AM EST
  17. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Oct. 21, 2013 | 06:50AM EST
  18. Quidel Wins FDA Clearance for Two Molecular Diagnostic Tests for Use on Life Tech's QuantStudio Dx

    Benzinga | Sep. 16, 2013 | 08:03AM EST
  19. Quidel Wins FDA Clearance for Sofia RSV Fluorescent Immunoassay

    Benzinga | Aug. 19, 2013 | 12:45PM EST
  20. Quidel Wins FDA Clearance for Sofia(R) hCG FIA

    Benzinga | Aug. 5, 2013 | 18:04PM EST
  21. Eli Lilly, Valeant, Quidel: Med Stocks On The Move

    IBD | Jan. 4, 2013 | 05:42AM EST
  22. Eli Lilly, Valeant, Quidel: Med Stocks On The Move

    IBD | Jan. 4, 2013 | 05:29AM EST
  23. Wedbush Securities Reiterates Neutral Rating, $13 PT on Quidel Corporation

    Benzinga | Dec. 31, 2012 | 04:26AM EST
  24. Quidel Announces FDA Clearance for AmpliVue(R) Hand-Held Test for Clostridium Difficile

    Benzinga | Dec. 17, 2012 | 06:07AM EST
  25. Quidel Corp. Reports Operating Results (10-Q)

    GuruFocus | Oct. 29, 2012 | 03:03AM EST
  26. UPDATE: Piper Jaffray Initiates Quidel at Overweight on Long-Term Outlook

    Benzinga | Oct. 4, 2012 | 07:31AM EST
  27. Health Care Sector Wrap

    FoxBusiness | Aug. 29, 2012 | 10:45AM EST
  28. Health Care Sector Wrap

    FoxBusiness | Aug. 14, 2012 | 10:46AM EST
  29. Quidel Corp. Reports Operating Results (10-Q)

    GuruFocus | Jul. 27, 2012 | 12:20PM EST
  30. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Jul. 10, 2012 | 20:57PM EST
  31. Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | Feb. 26, 2012 | 21:46PM EST
  32. Wedbush Maintains Neutral Rating on Quidel

    Benzinga | Dec. 28, 2011 | 01:31AM EST
Trading Center